686 related articles for article (PubMed ID: 16563836)
1. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
Lo YM
Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive antenatal RHD typing.
Van der Schoot CE; Soussan AA; Koelewijn J; Bonsel G; Paget-Christiaens LG; de Haas M
Transfus Clin Biol; 2006; 13(1-2):53-7. PubMed ID: 16564727
[TBL] [Abstract][Full Text] [Related]
3. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
[TBL] [Abstract][Full Text] [Related]
4. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma.
Ding C
Methods Mol Biol; 2008; 444():253-67. PubMed ID: 18425487
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
[TBL] [Abstract][Full Text] [Related]
7. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.
Li Y; Finning K; Daniels G; Hahn S; Zhong X; Holzgreve W
Prenat Diagn; 2008 Mar; 28(3):203-8. PubMed ID: 18241084
[TBL] [Abstract][Full Text] [Related]
9. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
10. Fetal RhD genotyping by analysis of maternal blood. A case report.
Tóth T; Papp C; Tóth-Pál E; Nagy B; Papp Z
J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
[TBL] [Abstract][Full Text] [Related]
11. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
Daniels G; Finning K; Martin P; Soothill P
Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
[TBL] [Abstract][Full Text] [Related]
12. Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation.
Li Y; Wenzel F; Holzgreve W; Hahn S
Electrophoresis; 2006 Oct; 27(19):3889-96. PubMed ID: 16972300
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art.
Lo YM
BJOG; 2009 Jan; 116(2):152-7. PubMed ID: 19076946
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.
Brojer E; Zupanska B; Guz K; Orziñska A; Kaliñska A
Transfusion; 2005 Sep; 45(9):1473-80. PubMed ID: 16131380
[TBL] [Abstract][Full Text] [Related]
15. Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications.
Avent ND; Madgett TE; Maddocks DG; Soothill PW
Curr Opin Obstet Gynecol; 2009 Apr; 21(2):175-9. PubMed ID: 19262379
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive fetal RhCE genotyping from maternal blood.
Geifman-Holtzman O; Grotegut CA; Gaughan JP; Holtzman EJ; Floro C; Hernandez E
BJOG; 2009 Jan; 116(2):144-51. PubMed ID: 18503573
[TBL] [Abstract][Full Text] [Related]
17. Size fractionation of cell-free DNA in maternal plasma and its application in noninvasive detection of fetal single gene point mutations.
Li Y; Holzgreve W; Hahn S
Methods Mol Biol; 2008; 444():239-51. PubMed ID: 18425486
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups.
Doescher A; Petershofen EK; Wagner FF; Schunter M; Müller TH
Transfusion; 2013 Feb; 53(2):353-62. PubMed ID: 22691192
[TBL] [Abstract][Full Text] [Related]
19. [Fetal RHD genotyping by PCR using plasma from D negative pregnant women].
Achargui S; Tijane M; Benchemsi N
Transfus Clin Biol; 2011 Feb; 18(1):13-9. PubMed ID: 21190884
[TBL] [Abstract][Full Text] [Related]
20. Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women.
Bombard AT; Akolekar R; Farkas DH; VanAgtmael AL; Aquino F; Oeth P; Nicolaides KH
Prenat Diagn; 2011 Aug; 31(8):802-8. PubMed ID: 21626507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
